Literature DB >> 12511056

Drug user treatment referrals and entry among participants of a needle exchange program.

Elise D Riley1, Mahboobeh Safaeian, Steffanie A Strathdee, Robert K Brooner, Peter Beilenson, David Vlahov.   

Abstract

OBJECTIVE: To compare characteristics of needle exchange program (NEP) participants who requested methadone treatment to those who did not, compare participants who subsequently enrolled into treatment to those who did not enroll, and suggest possible barriers to treatment among NEP participants. METHODS AND MATERIALS: Between 8/94 and 2/97, data pertaining to demographics and drug use were collected from Baltimore NEP participants upon registration. Participants were made aware that referrals to off-site methadone maintenance were available upon request. Odds ratios and multiple logistic regression models were used to compare those who requested treatment to those who did not and those who entered treatment to those who did not enter.
RESULTS: Among 2659 NEP participants, 86% were African-American, 28% were female, 9% were employed, and the median age was 38 years. Requesting a drug user treatment referral was associated with female gender [Adjusted Odds Ratio (AOR) = 2.02], age > 38 years (AOR = 1.96), use of speedballs during the past 6 months (AOR = 3.38), and age > 20 years at time of first injection (AOR = 1.59). Among 139 individuals who requested treatment, males were twice as likely as females to enter treatment (OR = 2.45). In an open-ended survey, health insurance (p = .02) and not living with children (p = .01) were associated with drug user treatment entry.
CONCLUSIONS: Even though female NEP participants were more likely to request methadone treatment, they were less likely than males to enter treatment. Although NEPs can be a bridge to drug user treatment, these data suggest that barriers to utilizing treatment referrals are important issues to resolve, especially for women who use community needle exchange programs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12511056     DOI: 10.1081/ja-120014088

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  19 in total

1.  Social contextual factors associated with entry into opiate agonist treatment among injection drug users.

Authors:  Jacqueline J Lloyd; Erin P Ricketts; Steffanie A Strathdee; Llewellyn J Cornelius; David Bishai; Steven Huettner; Jennifer R Havens; Carl Latkin
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

2.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

3.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

4.  Why don't out-of-treatment individuals enter methadone treatment programmes?

Authors:  James A Peterson; Robert P Schwartz; Shannon Gwin Mitchell; Heather Schacht Reisinger; Sharon M Kelly; Kevin E O'Grady; Barry S Brown; Michael H Agar
Journal:  Int J Drug Policy       Date:  2008-09-20

5.  Challenges in motivating treatment enrollment in community syringe exchange participants.

Authors:  Michael Kidorf; Elizabeth Disney; Van King; Ken Kolodner; Peter Beilenson; Robert K Brooner
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

6.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

7.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

8.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

9.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

10.  A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.

Authors:  Paul Truman Harrell; R C Trenz; M Scherer; S S Martins; W W Latimer
Journal:  J Subst Abuse Treat       Date:  2013-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.